vTv Therapeutics Inc. Revenue From Contract With Customer Excluding Assessed Tax

• vTv Therapeutics Inc. showed a decrease of -100.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from vTv Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), vTv Therapeutics Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
• Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $1.02 million | Fiscal year 2023: $0.00 | Fiscal year 2022: $2.02 million | Fiscal year 2021: $4.01 million | Fiscal year 2020: $6.41 million | Fiscal year 2019: $2.76 million | Fiscal year 2018: $12.43 million | Fiscal year 2017: $291.0 thousand | Fiscal year 2016: $634.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026